Medical Specialty Bags Market Size, Share & Trends Analysis Report By Product (Ostomy Collection Bags, Urinary Collection Bags, Blood Bags, Bile Collection Bags, Sterile Packaging Bags), Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 2 Business Days
Medical Specialty Bags Market Growth & Trends
The global medical specialty bags market size was estimated at USD 14.06 billion in 2030 and is expected t%li%grow at a CAGR of 4.4% from 2023 t%li%2030, according t%li%a new report by Grand View Research, Inc. Growing percentage of aging population and prevailing diseases such as urinary incontinence is expected t%li%be the key driving factor for market growth over the next seven years.
Government policies and initiatives intended t%li%draw customer attention by improving the cost-effectiveness of product offering is expected t%li%drive demand over the forecast period. Streamlined reimbursement policies t%li%make the product more attractive is als%li%expected t%li%play a major role in the growth of the medical specialty bag market over the forecast period.
Rise in the disposable income and growing health awareness regarding various diseases coupled with increasing unmet medical needs and the introduction of affordable medical specialty bags in emerging economies such as Brazil, China, and India is anticipated t%li%propel the future growth of the industry. High excise tax rates on healthcare devices in theU.S and Canada is expected t%li%serve as a key challenge for the medical specialty bags market over the next seven years.
Based on the type of product, the medical specialty bag market is broadly classified int%li%urinary collection bags, anesthesia breathing bags, sterile packaging bags, blood bags, bile collection bags, cadaver bags, ostomy bags, enteral feeding bags, intravenous fluid bags, and continuous ambulatory peritoneal dialysis bags. (CAPD).
Medical Specialty Bags Market Report Highlights
Medical Specialty Bags Market Growth & Trends
The global medical specialty bags market size was estimated at USD 14.06 billion in 2030 and is expected t%li%grow at a CAGR of 4.4% from 2023 t%li%2030, according t%li%a new report by Grand View Research, Inc. Growing percentage of aging population and prevailing diseases such as urinary incontinence is expected t%li%be the key driving factor for market growth over the next seven years.
Government policies and initiatives intended t%li%draw customer attention by improving the cost-effectiveness of product offering is expected t%li%drive demand over the forecast period. Streamlined reimbursement policies t%li%make the product more attractive is als%li%expected t%li%play a major role in the growth of the medical specialty bag market over the forecast period.
Rise in the disposable income and growing health awareness regarding various diseases coupled with increasing unmet medical needs and the introduction of affordable medical specialty bags in emerging economies such as Brazil, China, and India is anticipated t%li%propel the future growth of the industry. High excise tax rates on healthcare devices in theU.S and Canada is expected t%li%serve as a key challenge for the medical specialty bags market over the next seven years.
Based on the type of product, the medical specialty bag market is broadly classified int%li%urinary collection bags, anesthesia breathing bags, sterile packaging bags, blood bags, bile collection bags, cadaver bags, ostomy bags, enteral feeding bags, intravenous fluid bags, and continuous ambulatory peritoneal dialysis bags. (CAPD).
Medical Specialty Bags Market Report Highlights
- Ostomy collection bags was the largest product segment in 2013 and is estimated t%li%grow at a CAGR of 4.3% from 2014 t%li%2020 t%li%reach USD 2.94 billion. Bile collection bags, on the other hand, are expected t%li%grow at a fast pace with a CAGR of 6.5% from 2014 t%li%2020, on account of the rising need for minimally invasive laparoscopic cholecystectomy procedures.
- Intravenous (IV) fluid bags market revenue is estimated t%li%reach USD 2,469.9 million by 2020, growing at a CAGR of 5.2% from 2014 t%li%2020. Medical specialty bags comprise niche segments including home healthcare and SurgiCenters. Small non-hospital players such as SurgiCenters are expected t%li%drive the market growth owing t%li%increasing demand and customer awareness. These bags are used for surgeries in hospitals.
- North America accounted for the largest share of the market in 2013 owing t%li%the existence of sophisticated healthcare infrastructure, better patient awareness levels, and reimbursement framework. These elements are responsible for high rates of usage and procedure volumes in the region.
- Asia Pacific medical specialty bags markets expected t%li%grow at the highest CAGR of over 6.0% from 2014 t%li%2020. Improved medical knowledge, in addition t%li%improving healthcare infrastructure and disbursements, are some of the factors expected t%li%account for its rapid growth over the forecast period.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Regional scope
1.2.3. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Regional outlook
2.3. Competitive Insights
CHAPTER 3. MEDICAL SPECIALTY BAGS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Medical Specialty Bags Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Pipeline Analysis
CHAPTER 4. MEDICAL SPECIALTY BAGS MARKET: TREATMENT ESTIMATES & TREND ANALYSIS
4.1. Global Medical Specialty Bags Market: Product Dashboard
4.2. Global Medical Specialty Bags Market: Product Movement Analysis
4.3. Global Medical Specialty Bags Market by Product, Revenue
4.4. Ostomy Collection Bags
4.4.1. Ostomy Collection Bags market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Single use
4.4.2.1. Single use market estimates and segment forecasts 2018 to 2030 (USD Million)
4.4.3. Multiple use
4.4.3.1. Multiple use market estimates and segment forecasts 2018 to 2030 (USD Million)
4.5. Intravenous (IV) Fluid Bags
4.5.1. Intravenous (IV) fluid bags market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2. PVC
4.5.2.1. PVC market estimates and segment forecasts 2018 to 2030 (USD Million)
4.5.3. Non-PVC
4.5.3.1. Non-PVC market estimates and segment forecasts 2018 to 2030 (USD Million)
4.6. Continuous Ambulatory Peritoneal Dialysis (CAPD) Bags
4.6.1. Continuous ambulatory peritoneal dialysis (CAPD) Bags market estimates and forecasts 2018 to 2030 (USD Million)
4.6.2. Bags
4.6.2.1. Bags market estimates and segment forecasts 2018 to 2030 (USD Million)
4.6.3. Disposable
4.6.3.1. Disposable market estimates and segment forecasts 2018 to 2030 (USD Million)
4.6.4. Reusable
4.6.4.1. Reusable market estimates and segment forecasts 2018 to 2030 (USD Million)
4.7. Urinary Collection Bags
4.7.1. Urinary collection bags market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Sterile Packaging Bags
4.8.1. Sterile packaging bags market estimates and forecasts 2018 to 2030 (USD Million)
4.9. Anesthesia Breathing Bags
4.9.1. Anesthesia breathing bags market estimates and forecasts 2018 to 2030 (USD Million)
4.10. Cadaver (Body) Bags
4.10.1. Cadaver (Body) bags market estimates and forecasts 2018 to 2030 (USD Million)
4.11. Blood Bags
4.11.1. Blood bags market estimates and forecasts 2018 to 2030 (USD Million)
4.12. Enema Bags
4.12.1. Enema bags market estimates and forecasts 2018 to 2030 (USD Million)
4.13. Enteral Feeding Bags
4.13.1. Enteral feeding bags market estimates and forecasts 2018 to 2030 (USD Million)
4.14. Bile Collection Bags
4.14.1. Bile collection bags market estimates and forecasts 2018 to 2030 (USD Million)
4.15. Ice Bags
4.15.1. Ice Bags market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. MEDICAL SPECIALTY BAGS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY PRODUCT
5.1. Regional Dashboard
5.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
5.3. North America
5.3.1. U.S.
5.3.1.1. Key country dynamics
5.3.1.2. Regulatory framework/ reimbursement structure
5.3.1.3. Competitive scenario
5.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
5.3.2. Canada
5.3.2.1. Key country dynamics
5.3.2.2. Regulatory framework/ reimbursement structure
5.3.2.3. Competitive scenario
5.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
5.3.3. Mexico
5.3.3.1. Key country dynamics
5.3.3.2. Regulatory framework/ reimbursement structure
5.3.3.3. Competitive scenario
5.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
5.4. Europe
5.4.1. UK
5.4.1.1. Key country dynamics
5.4.1.2. Regulatory framework/ reimbursement structure
5.4.1.3. Competitive scenario
5.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Germany
5.4.2.1. Key country dynamics
5.4.2.2. Regulatory framework/ reimbursement structure
5.4.2.3. Competitive scenario
5.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. France
5.4.3.1. Key country dynamics
5.4.3.2. Regulatory framework/ reimbursement structure
5.4.3.3. Competitive scenario
5.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Italy
5.4.4.1. Key country dynamics
5.4.4.2. Regulatory framework/ reimbursement structure
5.4.4.3. Competitive scenario
5.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
5.4.5. Spain
5.4.5.1. Key country dynamics
5.4.5.2. Regulatory framework/ reimbursement structure
5.4.5.3. Competitive scenario
5.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
5.4.6. Norway
5.4.6.1. Key country dynamics
5.4.6.2. Regulatory framework/ reimbursement structure
5.4.6.3. Competitive scenario
5.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
5.4.7. Sweden
5.4.7.1. Key country dynamics
5.4.7.2. Regulatory framework/ reimbursement structure
5.4.7.3. Competitive scenario
5.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
5.4.8. Denmark
5.4.8.1. Key country dynamics
5.4.8.2. Regulatory framework/ reimbursement structure
5.4.8.3. Competitive scenario
5.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Asia Pacific
5.5.1. Japan
5.5.1.1. Key country dynamics
5.5.1.2. Regulatory framework/ reimbursement structure
5.5.1.3. Competitive scenario
5.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
5.5.2. China
5.5.2.1. Key country dynamics
5.5.2.2. Regulatory framework/ reimbursement structure
5.5.2.3. Competitive scenario
5.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
5.5.3. India
5.5.3.1. Key country dynamics
5.5.3.2. Regulatory framework/ reimbursement structure
5.5.3.3. Competitive scenario
5.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
5.5.4. Australia
5.5.4.1. Key country dynamics
5.5.4.2. Regulatory framework/ reimbursement structure
5.5.4.3. Competitive scenario
5.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
5.5.5. South Korea
5.5.5.1. Key country dynamics
5.5.5.2. Regulatory framework/ reimbursement structure
5.5.5.3. Competitive scenario
5.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
5.5.6. Thailand
5.5.6.1. Key country dynamics
5.5.6.2. Regulatory framework/ reimbursement structure
5.5.6.3. Competitive scenario
5.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Latin America
5.6.1. Brazil
5.6.1.1. Key country dynamics
5.6.1.2. Regulatory framework/ reimbursement structure
5.6.1.3. Competitive scenario
5.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
5.6.2. Argentina
5.6.2.1. Key country dynamics
5.6.2.2. Regulatory framework/ reimbursement structure
5.6.2.3. Competitive scenario
5.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
5.7. MEA
5.7.1. South Africa
5.7.1.1. Key country dynamics
5.7.1.2. Regulatory framework/ reimbursement structure
5.7.1.3. Competitive scenario
5.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
5.7.2. Saudi Arabia
5.7.2.1. Key country dynamics
5.7.2.2. Regulatory framework/ reimbursement structure
5.7.2.3. Competitive scenario
5.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
5.7.3. UAE
5.7.3.1. Key country dynamics
5.7.3.2. Regulatory framework/ reimbursement structure
5.7.3.3. Competitive scenario
5.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
5.7.4. Kuwait
5.7.4.1. Key country dynamics
5.7.4.2. Regulatory framework/ reimbursement structure
5.7.4.3. Competitive scenario
5.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Company/Competition Categorization
6.2. Vendor Landscape
6.2.1. List of key distributors and channel partners
6.2.2. Key customers
6.2.3. Key company market share analysis, 2023
6.2.4. B. Braun SE
6.2.4.1. Company overview
6.2.4.2. Financial performance
6.2.4.3. Product benchmarking
6.2.4.4. Strategic initiatives
6.2.5. Baxter
6.2.5.1. Company overview
6.2.5.2. Financial performance
6.2.5.3. Product benchmarking
6.2.5.4. Strategic initiatives
6.2.6. Bard
6.2.6.1. Company overview
6.2.6.2. Financial performance
6.2.6.3. Product benchmarking
6.2.6.4. Strategic initiatives
6.2.7. Coloplast A/S
6.2.7.1. Company overview
6.2.7.2. Financial performance
6.2.7.3. Product benchmarking
6.2.7.4. Strategic initiatives
6.2.8. Convatec Inc.
6.2.8.1. Company overview
6.2.8.2. Financial performance
6.2.8.3. Product benchmarking
6.2.8.4. Strategic initiatives
6.2.9. Fresenius Medical Care AG
6.2.9.1. Company overview
6.2.9.2. Financial performance
6.2.9.3. Product benchmarking
6.2.9.4. Strategic initiatives
6.2.10. Hollister Incorporated
6.2.10.1. Company overview
6.2.10.2. Financial performance
6.2.10.3. Product benchmarking
6.2.10.4. Strategic initiatives
6.2.11. SB-KAWASUMI LABORATORIES, INC.
6.2.11.1. Company overview
6.2.11.2. Financial performance
6.2.11.3. Product benchmarking
6.2.11.4. Strategic initiatives
6.2.12. Macopharma
6.2.12.1. Company overview
6.2.12.2. Financial performance
6.2.12.3. Product benchmarking
6.2.12.4. Strategic initiatives
6.2.13. Pall Corporation (Danaher)
6.2.13.1. Company overview
6.2.13.2. Financial performance
6.2.13.3. Product benchmarking
6.2.13.4. Strategic initiatives
6.2.14. Terumo Corporation
6.2.14.1. Company overview
6.2.14.2. Financial performance
6.2.14.3. Product benchmarking
6.2.14.4. Strategic initiatives
6.2.15. Westfield Medical Ltd.
6.2.15.1. Company overview
6.2.15.2. Financial performance
6.2.15.3. Product benchmarking
6.2.15.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Regional scope
1.2.3. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Regional outlook
2.3. Competitive Insights
CHAPTER 3. MEDICAL SPECIALTY BAGS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Medical Specialty Bags Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Pipeline Analysis
CHAPTER 4. MEDICAL SPECIALTY BAGS MARKET: TREATMENT ESTIMATES & TREND ANALYSIS
4.1. Global Medical Specialty Bags Market: Product Dashboard
4.2. Global Medical Specialty Bags Market: Product Movement Analysis
4.3. Global Medical Specialty Bags Market by Product, Revenue
4.4. Ostomy Collection Bags
4.4.1. Ostomy Collection Bags market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Single use
4.4.2.1. Single use market estimates and segment forecasts 2018 to 2030 (USD Million)
4.4.3. Multiple use
4.4.3.1. Multiple use market estimates and segment forecasts 2018 to 2030 (USD Million)
4.5. Intravenous (IV) Fluid Bags
4.5.1. Intravenous (IV) fluid bags market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2. PVC
4.5.2.1. PVC market estimates and segment forecasts 2018 to 2030 (USD Million)
4.5.3. Non-PVC
4.5.3.1. Non-PVC market estimates and segment forecasts 2018 to 2030 (USD Million)
4.6. Continuous Ambulatory Peritoneal Dialysis (CAPD) Bags
4.6.1. Continuous ambulatory peritoneal dialysis (CAPD) Bags market estimates and forecasts 2018 to 2030 (USD Million)
4.6.2. Bags
4.6.2.1. Bags market estimates and segment forecasts 2018 to 2030 (USD Million)
4.6.3. Disposable
4.6.3.1. Disposable market estimates and segment forecasts 2018 to 2030 (USD Million)
4.6.4. Reusable
4.6.4.1. Reusable market estimates and segment forecasts 2018 to 2030 (USD Million)
4.7. Urinary Collection Bags
4.7.1. Urinary collection bags market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Sterile Packaging Bags
4.8.1. Sterile packaging bags market estimates and forecasts 2018 to 2030 (USD Million)
4.9. Anesthesia Breathing Bags
4.9.1. Anesthesia breathing bags market estimates and forecasts 2018 to 2030 (USD Million)
4.10. Cadaver (Body) Bags
4.10.1. Cadaver (Body) bags market estimates and forecasts 2018 to 2030 (USD Million)
4.11. Blood Bags
4.11.1. Blood bags market estimates and forecasts 2018 to 2030 (USD Million)
4.12. Enema Bags
4.12.1. Enema bags market estimates and forecasts 2018 to 2030 (USD Million)
4.13. Enteral Feeding Bags
4.13.1. Enteral feeding bags market estimates and forecasts 2018 to 2030 (USD Million)
4.14. Bile Collection Bags
4.14.1. Bile collection bags market estimates and forecasts 2018 to 2030 (USD Million)
4.15. Ice Bags
4.15.1. Ice Bags market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. MEDICAL SPECIALTY BAGS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY PRODUCT
5.1. Regional Dashboard
5.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
5.3. North America
5.3.1. U.S.
5.3.1.1. Key country dynamics
5.3.1.2. Regulatory framework/ reimbursement structure
5.3.1.3. Competitive scenario
5.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
5.3.2. Canada
5.3.2.1. Key country dynamics
5.3.2.2. Regulatory framework/ reimbursement structure
5.3.2.3. Competitive scenario
5.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
5.3.3. Mexico
5.3.3.1. Key country dynamics
5.3.3.2. Regulatory framework/ reimbursement structure
5.3.3.3. Competitive scenario
5.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
5.4. Europe
5.4.1. UK
5.4.1.1. Key country dynamics
5.4.1.2. Regulatory framework/ reimbursement structure
5.4.1.3. Competitive scenario
5.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Germany
5.4.2.1. Key country dynamics
5.4.2.2. Regulatory framework/ reimbursement structure
5.4.2.3. Competitive scenario
5.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. France
5.4.3.1. Key country dynamics
5.4.3.2. Regulatory framework/ reimbursement structure
5.4.3.3. Competitive scenario
5.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Italy
5.4.4.1. Key country dynamics
5.4.4.2. Regulatory framework/ reimbursement structure
5.4.4.3. Competitive scenario
5.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
5.4.5. Spain
5.4.5.1. Key country dynamics
5.4.5.2. Regulatory framework/ reimbursement structure
5.4.5.3. Competitive scenario
5.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
5.4.6. Norway
5.4.6.1. Key country dynamics
5.4.6.2. Regulatory framework/ reimbursement structure
5.4.6.3. Competitive scenario
5.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
5.4.7. Sweden
5.4.7.1. Key country dynamics
5.4.7.2. Regulatory framework/ reimbursement structure
5.4.7.3. Competitive scenario
5.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
5.4.8. Denmark
5.4.8.1. Key country dynamics
5.4.8.2. Regulatory framework/ reimbursement structure
5.4.8.3. Competitive scenario
5.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Asia Pacific
5.5.1. Japan
5.5.1.1. Key country dynamics
5.5.1.2. Regulatory framework/ reimbursement structure
5.5.1.3. Competitive scenario
5.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
5.5.2. China
5.5.2.1. Key country dynamics
5.5.2.2. Regulatory framework/ reimbursement structure
5.5.2.3. Competitive scenario
5.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
5.5.3. India
5.5.3.1. Key country dynamics
5.5.3.2. Regulatory framework/ reimbursement structure
5.5.3.3. Competitive scenario
5.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
5.5.4. Australia
5.5.4.1. Key country dynamics
5.5.4.2. Regulatory framework/ reimbursement structure
5.5.4.3. Competitive scenario
5.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
5.5.5. South Korea
5.5.5.1. Key country dynamics
5.5.5.2. Regulatory framework/ reimbursement structure
5.5.5.3. Competitive scenario
5.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
5.5.6. Thailand
5.5.6.1. Key country dynamics
5.5.6.2. Regulatory framework/ reimbursement structure
5.5.6.3. Competitive scenario
5.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Latin America
5.6.1. Brazil
5.6.1.1. Key country dynamics
5.6.1.2. Regulatory framework/ reimbursement structure
5.6.1.3. Competitive scenario
5.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
5.6.2. Argentina
5.6.2.1. Key country dynamics
5.6.2.2. Regulatory framework/ reimbursement structure
5.6.2.3. Competitive scenario
5.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
5.7. MEA
5.7.1. South Africa
5.7.1.1. Key country dynamics
5.7.1.2. Regulatory framework/ reimbursement structure
5.7.1.3. Competitive scenario
5.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
5.7.2. Saudi Arabia
5.7.2.1. Key country dynamics
5.7.2.2. Regulatory framework/ reimbursement structure
5.7.2.3. Competitive scenario
5.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
5.7.3. UAE
5.7.3.1. Key country dynamics
5.7.3.2. Regulatory framework/ reimbursement structure
5.7.3.3. Competitive scenario
5.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
5.7.4. Kuwait
5.7.4.1. Key country dynamics
5.7.4.2. Regulatory framework/ reimbursement structure
5.7.4.3. Competitive scenario
5.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Company/Competition Categorization
6.2. Vendor Landscape
6.2.1. List of key distributors and channel partners
6.2.2. Key customers
6.2.3. Key company market share analysis, 2023
6.2.4. B. Braun SE
6.2.4.1. Company overview
6.2.4.2. Financial performance
6.2.4.3. Product benchmarking
6.2.4.4. Strategic initiatives
6.2.5. Baxter
6.2.5.1. Company overview
6.2.5.2. Financial performance
6.2.5.3. Product benchmarking
6.2.5.4. Strategic initiatives
6.2.6. Bard
6.2.6.1. Company overview
6.2.6.2. Financial performance
6.2.6.3. Product benchmarking
6.2.6.4. Strategic initiatives
6.2.7. Coloplast A/S
6.2.7.1. Company overview
6.2.7.2. Financial performance
6.2.7.3. Product benchmarking
6.2.7.4. Strategic initiatives
6.2.8. Convatec Inc.
6.2.8.1. Company overview
6.2.8.2. Financial performance
6.2.8.3. Product benchmarking
6.2.8.4. Strategic initiatives
6.2.9. Fresenius Medical Care AG
6.2.9.1. Company overview
6.2.9.2. Financial performance
6.2.9.3. Product benchmarking
6.2.9.4. Strategic initiatives
6.2.10. Hollister Incorporated
6.2.10.1. Company overview
6.2.10.2. Financial performance
6.2.10.3. Product benchmarking
6.2.10.4. Strategic initiatives
6.2.11. SB-KAWASUMI LABORATORIES, INC.
6.2.11.1. Company overview
6.2.11.2. Financial performance
6.2.11.3. Product benchmarking
6.2.11.4. Strategic initiatives
6.2.12. Macopharma
6.2.12.1. Company overview
6.2.12.2. Financial performance
6.2.12.3. Product benchmarking
6.2.12.4. Strategic initiatives
6.2.13. Pall Corporation (Danaher)
6.2.13.1. Company overview
6.2.13.2. Financial performance
6.2.13.3. Product benchmarking
6.2.13.4. Strategic initiatives
6.2.14. Terumo Corporation
6.2.14.1. Company overview
6.2.14.2. Financial performance
6.2.14.3. Product benchmarking
6.2.14.4. Strategic initiatives
6.2.15. Westfield Medical Ltd.
6.2.15.1. Company overview
6.2.15.2. Financial performance
6.2.15.3. Product benchmarking
6.2.15.4. Strategic initiatives
LIST OF TABLES
Table 1 List of abbreviation
Table 2 North America medical specialty bags market, by region, 2018 - 2030 (USD Million)
Table 3 North America medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 4 U.S. medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 5 Canada medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 6 Mexico medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 7 Europe medical specialty bags market, by region, 2018 - 2030 (USD Million)
Table 8 Europe medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 9 Germany medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 10 UK medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 11 France medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 12 Italy medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 13 Spain medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 14 Denmark medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 15 Sweden medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 16 Norway medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 17 Asia Pacific medical specialty bags market, by region, 2018 - 2030 (USD Million)
Table 18 Asia Pacific medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 19 China medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 20 Japan medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 21 India medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 22 South Korea medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 23 Australia medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 24 Thailand medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 25 Latin America medical specialty bags market, by region, 2018 - 2030 (USD Million)
Table 26 Latin America medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 27 Brazil medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 28 Argentina medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 29 MEA medical specialty bags market, by region, 2018 - 2030 (USD Million)
Table 30 MEA medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 31 South Africa medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 32 Saudi Arabia medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 33 UAE medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 34 Kuwait medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 1 List of abbreviation
Table 2 North America medical specialty bags market, by region, 2018 - 2030 (USD Million)
Table 3 North America medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 4 U.S. medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 5 Canada medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 6 Mexico medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 7 Europe medical specialty bags market, by region, 2018 - 2030 (USD Million)
Table 8 Europe medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 9 Germany medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 10 UK medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 11 France medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 12 Italy medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 13 Spain medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 14 Denmark medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 15 Sweden medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 16 Norway medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 17 Asia Pacific medical specialty bags market, by region, 2018 - 2030 (USD Million)
Table 18 Asia Pacific medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 19 China medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 20 Japan medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 21 India medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 22 South Korea medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 23 Australia medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 24 Thailand medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 25 Latin America medical specialty bags market, by region, 2018 - 2030 (USD Million)
Table 26 Latin America medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 27 Brazil medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 28 Argentina medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 29 MEA medical specialty bags market, by region, 2018 - 2030 (USD Million)
Table 30 MEA medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 31 South Africa medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 32 Saudi Arabia medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 33 UAE medical specialty bags market, by product, 2018 - 2030 (USD Million)
Table 34 Kuwait medical specialty bags market, by product, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Surgical Blade market segment scope and defination
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2023)
Fig. 10 Strategy framework
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Porter’s five forces analysis
Fig. 15 PESTLE analysis
Fig. 16 Surgical Blade market: Product movement analysis
Fig. 17 Surgical Blade market: Product segment dashboard
Fig. 18 Surgical Blade market Product outlook: Key takeaways
Fig. 19 Stainless steel surgical blade market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 High-grade carbon steel surgical blade market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Other surgical blade market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Surgical blade market: Material movement analysis
Fig. 23 Surgical blade market Material outlook: Key takeaways
Fig. 24 Sterile surgical blade market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Non-sterile surgical blade market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Surgical blade market: End use movement analysis
Fig. 27 Surgical blade market End use outlook: Key takeaways
Fig. 28 Hospitals surgical blade market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Clinics surgical blade market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Ambulatory surgical centers surgical blade market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Regional outlook, 2023 & 2030
Fig. 32 Regional market dashboard
Fig. 33 Regional market place: Key takeaways
Fig. 34 North America Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 35 U.S. Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 36 Canada Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 37 Mexico Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 38 Europe Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 39 UK Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 40 Germany Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 41 Spain Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 42 France Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 43 Italy implantable Market, 2018 - 2030 (USD Million)
Fig. 44 Denmark Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 45 Sweden Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 46 Norway Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 47 Asia Pacific Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 48 Japan Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 49 China Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 50 India Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 51 South Korea Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 52 Australia Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 53 Thailand Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 54 Latin America Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 55 Brazil Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 56 Argentina Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 57 MEA Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 58 South Africa Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 59 Saudi Arabia Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 60 UAE Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 61 Kuwait Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 62 Heat map analysis
Fig. 63 Market differentiators
Fig. 1 Surgical Blade market segment scope and defination
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2023)
Fig. 10 Strategy framework
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Porter’s five forces analysis
Fig. 15 PESTLE analysis
Fig. 16 Surgical Blade market: Product movement analysis
Fig. 17 Surgical Blade market: Product segment dashboard
Fig. 18 Surgical Blade market Product outlook: Key takeaways
Fig. 19 Stainless steel surgical blade market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 High-grade carbon steel surgical blade market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Other surgical blade market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Surgical blade market: Material movement analysis
Fig. 23 Surgical blade market Material outlook: Key takeaways
Fig. 24 Sterile surgical blade market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Non-sterile surgical blade market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Surgical blade market: End use movement analysis
Fig. 27 Surgical blade market End use outlook: Key takeaways
Fig. 28 Hospitals surgical blade market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Clinics surgical blade market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Ambulatory surgical centers surgical blade market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Regional outlook, 2023 & 2030
Fig. 32 Regional market dashboard
Fig. 33 Regional market place: Key takeaways
Fig. 34 North America Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 35 U.S. Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 36 Canada Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 37 Mexico Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 38 Europe Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 39 UK Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 40 Germany Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 41 Spain Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 42 France Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 43 Italy implantable Market, 2018 - 2030 (USD Million)
Fig. 44 Denmark Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 45 Sweden Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 46 Norway Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 47 Asia Pacific Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 48 Japan Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 49 China Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 50 India Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 51 South Korea Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 52 Australia Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 53 Thailand Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 54 Latin America Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 55 Brazil Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 56 Argentina Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 57 MEA Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 58 South Africa Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 59 Saudi Arabia Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 60 UAE Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 61 Kuwait Surgical Blade Market, 2018 - 2030 (USD Million)
Fig. 62 Heat map analysis
Fig. 63 Market differentiators
